AI in Epidemiology Market Size, Share & Trends Analysis Report by Component (Software, Hardware, Services), Technology, Deployment Mode, Disease Type, Data Source, Application, End User, and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) – Global Industry Data, Trends, and Forecasts, 2026–2035
|
|
|
Segmental Data Insights |
|
|
Demand Trends |
|
|
Competitive Landscape |
|
|
Strategic Development |
|
|
Future Outlook & Opportunities |
|
AI in Epidemiology market Size, Share, and Growth
The global AI in epidemiology market is witnessing strong growth, valued at USD 0.4 billion in 2025 and projected to reach USD 3.3 billion by 2035, expanding at a CAGR of 24.1% during the forecast period. AI in epidemiology enables modern public health systems to monitor, analyze, and manage disease spread through data-driven and highly predictive intelligence models, by leveraging machine learning algorithms, real-time surveillance inputs, and integrated health data ecosystems.
“During the COVID-19 pandemic, we saw firsthand how crucial accurate and timely interpretation of diagnostic data was in shaping public health policies and clinical outcomes. Now, as we confront increasingly complex threats such as antimicrobial resistance, viral mutations and co-infections, the ability to deliver actionable insights from diagnostic data is becoming a cornerstone of clinical innovation and a vital pillar of global health security.
Advanced machine learning systems, cloud native analytics and real-time population health intelligence are driving the AI in epidemiology market and enabling more accurate interpretation of disease spread patterns based on clinical, environmental and demographic data. This shift is helping health systems better prepare for outbreaks and respond effectively to new public health challenges.
Automated data harmonization tools and AI-powered pattern recognition engines are becoming more common on epidemiological platforms to turn unstructured health data into structured outbreak intelligence, quicker and more accurately identifying outbreaks. These technologies are making the shift from traditional surveillance systems to data-driven, continuous surveillance ecosystems easier.
The rise of AI in epidemiology is creating an expanding adjacent opportunity as AI is becoming part of a more integrated global health intelligence model that integrates genomic surveillance, mobility analytics, and environmental risk mapping for more coordinated and predictive public health decision-making at regional and global levels.
AI in Epidemiology market Dynamics and Trends
Driver: Rising Demand for Predictive Disease Surveillance and Early Outbreak Detection
- The widespread adoption of AI-powered disease surveillance systems with real-time outbreak detection and predictive monitoring is bolstering the growth of the global AI in epidemiology market, as it is spurring faster response times to the spread of infectious diseases across healthcare ecosystems.
- AI-driven epidemiological monitoring systems are being increasingly enhanced by governments and public health agencies to boost their early warning capabilities and accuracy of disease tracking. In November 2025, India pledged to boost disease surveillance through AI-powered systems to facilitate real-time analysis of health data and better prediction of epidemic threats in various regions.
- The global AI in epidemiology market will continue to grow as more AI-driven predictive surveillance platforms, AI health monitoring systems, and data-informed outbreak intelligence networks are deployed.
Restraint: Data Privacy, Regulatory Complexity, and Fragmented Health Data Infrastructure
- The adoption of AI in epidemiology is hindered by privacy and security concerns over the use of AI epidemiological systems that process sensitive health, genomic, and mobility data in several regions of the global AI in Epidemiology market.
- Regulatory variations between countries and tight cross-border data governance are creating more complexity and costs for the adoption and use of AI platforms for public health and surveillance activities.
- Fragmented healthcare data systems and the absence of interoperability among health databases are some of the factors which limit the growth of AI in epidemiology market.
Opportunity: Expansion of Cloud-Based Public Health Intelligence Platforms
- The transition towards real-time epidemic preparedness and cloud-based surveillance systems is another key factor in the expansion of the global AI in epidemiology market, with health authorities increasingly turning to AI-powered platforms that boost the efficiency of outbreak monitoring and response.
- Cloud-based epidemiology platforms are undergoing transformation with the introduction of AI-powered genomic surveillance, and the integration of health data by combining clinical, environmental, and pathogen level inputs to improve speed of disease detection and predictive analysis. In December 2025, the Asia Pathogen Genomics Initiative launched PathGen as a cloud-based outbreak intelligence platform aimed at improving epidemic preparedness across the region by integrating multi-source data from various countries.
- Cloud-based disease intelligence platforms and AI-driven public health surveillance networks will drive the growth of the AI in epidemiology market as they will become more widely adopted globally.
Key Trend: Integration of Machine Learning and Multi-Source Health Data Analytics
- The global AI in epidemiology market is growing as machine learning models and multi-source health intelligence systems are increasingly being adopted for more rapid insights into disease patterns through integrated clinical, genomic, and population-level inputs.
- Epidemiology platforms are moving toward a system of predictive analytics systems that integrate field outbreak information with AI-powered surveillance technologies for better decision making and early warning. In June 2026, ICMR-National Institute of epidemiology introduced AI-based epidemic intelligence platform 'ADARV' to enhance epidemic response by integrating and analysing data.
- Increased deployment of AI-based disease surveillance systems and multi-source predictive health analytics systems in the global region is projected to accelerate the market growth of AI in epidemiology.
AI in Epidemiology Market Analysis and Segmental Data
Disease Surveillance Dominate Global AI in Epidemiology Market
- Disease surveillance leads the global AI in epidemiology market, as AI is being increasingly adopted for real-time outbreak detection, infectious disease monitoring, and population health risk assessment, improving speed and timely public health response.
- Healthcare organisations and public health authorities are increasingly using AI-driven surveillance systems that combine electronic health records, laboratory testing data, environmental data and mobility data to enhance early warning systems and epidemiological decision-making.
- The rising trend of implementing AI-driven disease monitoring systems and real-time epidemiological intelligence still maintains its status as the biggest contributor to the global market of AI in epidemiology.
North America Leads Global AI in Epidemiology Market Demand
- North America leads the AI in epidemiology market, as AI-based disease surveillance is rapidly gaining adoption, and there is a high availability of real-world health data, along with significant investments in disease surveillance and public health analytics.
- The healthcare IT industry is advancing with sophisticated technologies such as healthcare IT infrastructure, cloud-based analytics and growing usage of predictive epidemiology platforms among healthcare and research institutions.
- North America is at the forefront of the global AI in epidemiology market with its well-developed AI ecosystem, sophisticated healthcare systems, and extensive efforts in public–private partnerships for disease intelligence.
AI in Epidemiology Market Ecosystem
The AI in epidemiology market is moderately consolidated, with the market rapidly changing as the public health sector increasingly turns to artificial intelligence for disease surveillance and forecasting, population health analytics, and public health decisions. AI, cloud computing, real-world data and advanced analytics are reshaping the ecosystem by empowering quicker epidemiological modeling, real-time monitoring and evidence-based healthcare interventions.
Major players in the market include International Business Machines Corporation (IBM), IQVIA Inc., SAS Institute Inc., Databricks, Inc., and Clarivate, which provide AI-driven analytics solutions, predictive modeling, real-world evidence solutions, and data integration. These firms are places their emphasis in machine learning, natural language processing, cloud-based analytics, and scalable data platforms to boost disease forecasting, epidemiological studies, and public health intelligence.
The implementation of EHRs, genomic databases, population health data, and real-time surveillance systems further contributes to the growth of the ecosystems. The ecosystems are also bolstered by the integration of electronic health records (EHRs), genomic databases, population health data, and real-time surveillance systems, all of which provide insights into epidemiology.
The partnership of the technology suppliers, healthcare institutions, research institutions, and public health institutions is driving innovation increasingly quickly, and the progress of interoperability in AI platforms and the sharing of information is further improving the world's AI in epidemiology ecosystem.
Recent Development and Strategic Overview
- In July 2025, Seegene released STAgora, an artificial intelligence (AI) based infectious disease analytics platform, which is able to integrate real-time PCR diagnostics data and statistical modeling in order to detect any outbreaks early and predict the epidemiology of infectious diseases.
- In April 2025, Boston University unveiled BEACON (Biothreats Emergence, Analysis, and Communications Network), an open-source AI-powered platform for global infectious disease surveillance that can identify and monitor emerging outbreaks as they happen by analyzing data streams from around the world and continuously refining its analytical capabilities through expert validation.
Report Scope
|
Detail |
|
|
Market Size in 2025 |
USD 0.4 Bn |
|
Market Forecast Value in 2035 |
USD 3.3 Bn |
|
Growth Rate (CAGR) |
24.1% |
|
Forecast Period |
2026 – 2035 |
|
Historical Data Available for |
2021 – 2024 |
|
Market Size Units |
US$ Billion for Value |
|
Report Format |
Electronic (PDF) + Excel |
|
North America |
Europe |
Asia Pacific |
Middle East |
Africa |
South America |
|
|
|
|
|
|
|
Companies Covered |
|||||
|
|
|
|
|
||
AI in Epidemiology Market Segmentation and Highlights
|
Segment |
Sub-segment |
|
AI in Epidemiology Market, By Component |
|
|
AI in Epidemiology Market, By Technology |
|
|
AI in Epidemiology Market, By Deployment Mode |
|
|
AI in Epidemiology Market, By Disease Type |
|
|
AI in Epidemiology Market, By Data Source |
|
|
AI in Epidemiology Market, By Application |
|
|
AI in Epidemiology Market, By End User |
|
Frequently Asked Questions
Table of Contents
- 1. Research Methodology and Assumptions
- 1.1. Definitions
- 1.2. Research Design and Approach
- 1.3. Data Collection Methods
- 1.4. Base Estimates and Calculations
- 1.5. Forecasting Models
- 1.5.1. Key Forecast Factors & Impact Analysis
- 1.6. Secondary Research
- 1.6.1. Open Sources
- 1.6.2. Paid Databases
- 1.6.3. Associations
- 1.7. Primary Research
- 1.7.1. Primary Sources
- 1.7.2. Primary Interviews with Stakeholders across Ecosystem
- 2. Executive Summary
- 2.1. Global AI in Epidemiology Market Outlook
- 2.1.1. AI in Epidemiology Market Size (Value - US$ Bn), and Forecasts, 2021-2035
- 2.1.2. Compounded Annual Growth Rate Analysis
- 2.1.3. Growth Opportunity Analysis
- 2.1.4. Segmental Share Analysis
- 2.1.5. Geographical Share Analysis
- 2.2. Market Analysis and Facts
- 2.3. Supply-Demand Analysis
- 2.4. Competitive Benchmarking
- 2.5. Go-to- Market Strategy
- 2.5.1. Customer/ End-use Industry Assessment
- 2.5.2. Growth Opportunity Data, 2026-2035
- 2.5.2.1. Regional Data
- 2.5.2.2. Country Data
- 2.5.2.3. Segmental Data
- 2.5.3. Identification of Potential Market Spaces
- 2.5.4. GAP Analysis
- 2.5.5. Potential Attractive Price Points
- 2.5.6. Prevailing Market Risks & Challenges
- 2.5.7. Preferred Sales & Marketing Strategies
- 2.5.8. Key Recommendations and Analysis
- 2.5.9. A Way Forward
- 2.1. Global AI in Epidemiology Market Outlook
- 3. Industry Data and Premium Insights
- 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
- 3.1.1. Healthcare & Pharmaceutical Industry Ecosystem Analysis
- 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
- 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
- 3.2. Supplier Customer Data
- 3.3. Technology Roadmap and Developments
- 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
- 4. Market Overview
- 4.1. Market Dynamics
- 4.1.1. Drivers
- 4.1.1.1. Rising adoption of AI for disease surveillance and outbreak prediction
- 4.1.1.2. Growing availability of real-world health data and electronic health records (EHRs)
- 4.1.1.3. Increasing government and public health investments in AI-powered epidemiological research
- 4.1.2. Restraints
- 4.1.2.1. Data privacy, security, and regulatory compliance challenges
- 4.1.2.2. Limited availability of high-quality, standardized epidemiological datasets
- 4.1.1. Drivers
- 4.2. Key Trend Analysis
- 4.3. Regulatory Framework
- 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
- 4.3.2. Tariffs and Standards
- 4.3.3. Impact Analysis of Regulations on the Market
- 4.4. Ecosystem Analysis
- 4.5. Porter’s Five Forces Analysis
- 4.6. PESTEL Analysis
- 4.7. Global AI in Epidemiology Market Demand
- 4.7.1. Historical Market Size – Value (US$ Bn), 2020-2024
- 4.7.2. Current and Future Market Size – Value (US$ Bn), 2026–2035
- 4.7.2.1. Y-o-Y Growth Trends
- 4.7.2.2. Absolute $ Opportunity Assessment
- 4.1. Market Dynamics
- 5. Competition Landscape
- 5.1. Competition structure
- 5.1.1. Fragmented v/s consolidated
- 5.2. Company Share Analysis, 2025
- 5.2.1. Global Company Market Share
- 5.2.2. By Region
- 5.2.2.1. North America
- 5.2.2.2. Europe
- 5.2.2.3. Asia Pacific
- 5.2.2.4. Middle East
- 5.2.2.5. Africa
- 5.2.2.6. South America
- 5.3. Product Comparison Matrix
- 5.3.1. Specifications
- 5.3.2. Market Positioning
- 5.3.3. Pricing
- 5.1. Competition structure
- 6. Global AI in Epidemiology Market Analysis, by Component
- 6.1. Key Segment Analysis
- 6.2. AI in Epidemiology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Component, 2021-2035
- 6.2.1. Software
- 6.2.1.1. Disease Surveillance Software
- 6.2.1.2. Outbreak Prediction & Epidemiological Modeling Software
- 6.2.1.3. Population Health Analytics Software
- 6.2.1.4. Public Health Decision Support Software
- 6.2.1.5. Data Integration & Visualization Software
- 6.2.1.6. AI Reporting & Analytics Software
- 6.2.1.7. Others
- 6.2.2. Hardware
- 6.2.2.1. AI Servers & High-Performance Computing (HPC) Systems
- 6.2.2.2. Data Storage Systems
- 6.2.2.3. Networking & Communication Infrastructure
- 6.2.2.4. Edge Computing & IoT Devices
- 6.2.2.5. Workstations & Monitoring Devices
- 6.2.2.6. Others
- 6.2.3. Services
- 6.2.3.1. AI Consulting & System Integration Services
- 6.2.3.2. AI Model Development & Deployment Services
- 6.2.3.3. Managed AI & Cloud Services
- 6.2.3.4. Data Analytics Services
- 6.2.3.5. Technical Support, Training & Compliance Services
- 6.2.3.6. Others
- 6.2.1. Software
- 7. Global AI in Epidemiology Market Analysis, by Technology
- 7.1. Key Segment Analysis
- 7.2. AI in Epidemiology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Technology, 2021-2035
- 7.2.1. Machine Learning (ML)
- 7.2.2. Deep Learning
- 7.2.3. Natural Language Processing (NLP)
- 7.2.4. Computer Vision
- 7.2.5. Predictive Analytics
- 7.2.6. Generative AI
- 7.2.7. Big Data Analytics
- 7.2.8. Geographic Information Systems (GIS)-Integrated AI
- 7.2.9. Others
- 8. Global AI in Epidemiology Market Analysis, by Deployment Mode
- 8.1. Key Segment Analysis
- 8.2. AI in Epidemiology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Deployment Mode, 2021-2035
- 8.2.1. Cloud-Based
- 8.2.2. On-Premises
- 8.2.3. Hybrid
- 9. Global AI in Epidemiology Market Analysis, by Disease Type
- 9.1. Key Segment Analysis
- 9.2. AI in Epidemiology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Disease Type, 2021-2035
- 9.2.1. Infectious Diseases
- 9.2.2. Chronic Diseases
- 9.2.3. Cardiovascular Diseases
- 9.2.4. Cancer
- 9.2.5. Respiratory Diseases
- 9.2.6. Neurological Disorders
- 9.2.7. Vector-Borne Diseases
- 9.2.8. Rare Diseases
- 9.2.9. Others
- 10. Global AI in Epidemiology Market Analysis, by Data Source
- 10.1. Key Segment Analysis
- 10.2. AI in Epidemiology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Data Source, 2021-2035
- 10.2.1. Electronic Health Records (EHRs)
- 10.2.2. Laboratory Data
- 10.2.3. Genomic Data
- 10.2.4. Wearable Device Data
- 10.2.5. Claims & Insurance Data
- 10.2.6. Social Media Data
- 10.2.7. Environmental & Climate Data
- 10.2.8. Public Health Databases
- 10.2.9. Others
- 11. Global AI in Epidemiology Market Analysis, by Application
- 11.1. Key Segment Analysis
- 11.2. AI in Epidemiology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Application, 2021-2035
- 11.2.1. Disease Surveillance
- 11.2.2. Outbreak Prediction & Forecasting
- 11.2.3. Contact Tracing
- 11.2.4. Population Health Management
- 11.2.5. Risk Assessment & Modeling
- 11.2.6. Public Health Decision Support
- 11.2.7. Clinical Epidemiology
- 11.2.8. Genomic Epidemiology
- 11.2.9. Vaccine Surveillance
- 11.2.10. Antimicrobial Resistance Monitoring
- 11.2.11. Environmental Health Monitoring
- 11.2.12. Health Data Analytics
- 11.2.13. Others
- 12. Global AI in Epidemiology Market Analysis, by End User
- 12.1. Key Segment Analysis
- 12.2. AI in Epidemiology Market Size (Value - US$ Bn), Analysis, and Forecasts, by End User, 2021-2035
- 12.2.1. Public Health Agencies
- 12.2.2. Hospitals & Healthcare Providers
- 12.2.3. Research Institutes
- 12.2.4. Academic Institutions
- 12.2.5. Pharmaceutical & Biotechnology Companies
- 12.2.6. Contract Research Organizations (CROs)
- 12.2.7. Government Organizations
- 12.2.8. Non-Governmental Organizations (NGOs)
- 12.2.9. Others
- 13. Global AI in Epidemiology Market Analysis and Forecasts, by Region
- 13.1. Key Findings
- 13.2. AI in Epidemiology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
- 13.2.1. North America
- 13.2.2. Europe
- 13.2.3. Asia Pacific
- 13.2.4. Middle East
- 13.2.5. Africa
- 13.2.6. South America
- 14. North America AI in Epidemiology Market Analysis
- 14.1. Key Segment Analysis
- 14.2. Regional Snapshot
- 14.3. North America AI in Epidemiology Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 14.3.1. Component
- 14.3.2. Technology
- 14.3.3. Deployment Mode
- 14.3.4. Disease Type
- 14.3.5. Data Source
- 14.3.6. Application
- 14.3.7. End User
- 14.3.8. Country
- 14.3.8.1. USA
- 14.3.8.2. Canada
- 14.3.8.3. Mexico
- 14.4. USA AI in Epidemiology Market
- 14.4.1. Country Segmental Analysis
- 14.4.2. Component
- 14.4.3. Technology
- 14.4.4. Deployment Mode
- 14.4.5. Disease Type
- 14.4.6. Data Source
- 14.4.7. Application
- 14.4.8. End User
- 14.5. Canada AI in Epidemiology Market
- 14.5.1. Country Segmental Analysis
- 14.5.2. Component
- 14.5.3. Technology
- 14.5.4. Deployment Mode
- 14.5.5. Disease Type
- 14.5.6. Data Source
- 14.5.7. Application
- 14.5.8. End User
- 14.6. Mexico AI in Epidemiology Market
- 14.6.1. Country Segmental Analysis
- 14.6.2. Component
- 14.6.3. Technology
- 14.6.4. Deployment Mode
- 14.6.5. Disease Type
- 14.6.6. Data Source
- 14.6.7. Application
- 14.6.8. End User
- 15. Europe AI in Epidemiology Market Analysis
- 15.1. Key Segment Analysis
- 15.2. Regional Snapshot
- 15.3. Europe AI in Epidemiology Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 15.3.1. Component
- 15.3.2. Technology
- 15.3.3. Deployment Mode
- 15.3.4. Disease Type
- 15.3.5. Data Source
- 15.3.6. Application
- 15.3.7. End User
- 15.3.8. Country
- 15.3.8.1. Germany
- 15.3.8.2. United Kingdom
- 15.3.8.3. France
- 15.3.8.4. Italy
- 15.3.8.5. Spain
- 15.3.8.6. Netherlands
- 15.3.8.7. Nordic Countries
- 15.3.8.8. Poland
- 15.3.8.9. Russia & CIS
- 15.3.8.10. Rest of Europe
- 15.4. Germany AI in Epidemiology Market
- 15.4.1. Country Segmental Analysis
- 15.4.2. Component
- 15.4.3. Technology
- 15.4.4. Deployment Mode
- 15.4.5. Disease Type
- 15.4.6. Data Source
- 15.4.7. Application
- 15.4.8. End User
- 15.5. United Kingdom AI in Epidemiology Market
- 15.5.1. Country Segmental Analysis
- 15.5.2. Component
- 15.5.3. Technology
- 15.5.4. Deployment Mode
- 15.5.5. Disease Type
- 15.5.6. Data Source
- 15.5.7. Application
- 15.5.8. End User
- 15.6. France AI in Epidemiology Market
- 15.6.1. Country Segmental Analysis
- 15.6.2. Component
- 15.6.3. Technology
- 15.6.4. Deployment Mode
- 15.6.5. Disease Type
- 15.6.6. Data Source
- 15.6.7. Application
- 15.6.8. End User
- 15.7. Italy AI in Epidemiology Market
- 15.7.1. Country Segmental Analysis
- 15.7.2. Component
- 15.7.3. Technology
- 15.7.4. Deployment Mode
- 15.7.5. Disease Type
- 15.7.6. Data Source
- 15.7.7. Application
- 15.7.8. End User
- 15.8. Spain AI in Epidemiology Market
- 15.8.1. Country Segmental Analysis
- 15.8.2. Component
- 15.8.3. Technology
- 15.8.4. Deployment Mode
- 15.8.5. Disease Type
- 15.8.6. Data Source
- 15.8.7. Application
- 15.8.8. End User
- 15.9. Netherlands AI in Epidemiology Market
- 15.9.1. Country Segmental Analysis
- 15.9.2. Component
- 15.9.3. Technology
- 15.9.4. Deployment Mode
- 15.9.5. Disease Type
- 15.9.6. Data Source
- 15.9.7. Application
- 15.9.8. End User
- 15.10. Nordic Countries AI in Epidemiology Market
- 15.10.1. Country Segmental Analysis
- 15.10.2. Component
- 15.10.3. Technology
- 15.10.4. Deployment Mode
- 15.10.5. Disease Type
- 15.10.6. Data Source
- 15.10.7. Application
- 15.10.8. End User
- 15.11. Poland AI in Epidemiology Market
- 15.11.1. Country Segmental Analysis
- 15.11.2. Component
- 15.11.3. Technology
- 15.11.4. Deployment Mode
- 15.11.5. Disease Type
- 15.11.6. Data Source
- 15.11.7. Application
- 15.11.8. End User
- 15.12. Russia & CIS AI in Epidemiology Market
- 15.12.1. Country Segmental Analysis
- 15.12.2. Component
- 15.12.3. Technology
- 15.12.4. Deployment Mode
- 15.12.5. Disease Type
- 15.12.6. Data Source
- 15.12.7. Application
- 15.12.8. End User
- 15.13. Rest of Europe AI in Epidemiology Market
- 15.13.1. Country Segmental Analysis
- 15.13.2. Component
- 15.13.3. Technology
- 15.13.4. Deployment Mode
- 15.13.5. Disease Type
- 15.13.6. Data Source
- 15.13.7. Application
- 15.13.8. End User
- 16. Asia Pacific AI in Epidemiology Market Analysis
- 16.1. Key Segment Analysis
- 16.2. Regional Snapshot
- 16.3. Asia Pacific AI in Epidemiology Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 16.3.1. Component
- 16.3.2. Technology
- 16.3.3. Deployment Mode
- 16.3.4. Disease Type
- 16.3.5. Data Source
- 16.3.6. Application
- 16.3.7. End User
- 16.3.8. Country
- 16.3.8.1. China
- 16.3.8.2. India
- 16.3.8.3. Japan
- 16.3.8.4. South Korea
- 16.3.8.5. Australia and New Zealand
- 16.3.8.6. Indonesia
- 16.3.8.7. Malaysia
- 16.3.8.8. Thailand
- 16.3.8.9. Vietnam
- 16.3.8.10. Rest of Asia Pacific
- 16.4. China AI in Epidemiology Market
- 16.4.1. Country Segmental Analysis
- 16.4.2. Component
- 16.4.3. Technology
- 16.4.4. Deployment Mode
- 16.4.5. Disease Type
- 16.4.6. Data Source
- 16.4.7. Application
- 16.4.8. End User
- 16.5. India AI in Epidemiology Market
- 16.5.1. Country Segmental Analysis
- 16.5.2. Component
- 16.5.3. Technology
- 16.5.4. Deployment Mode
- 16.5.5. Disease Type
- 16.5.6. Data Source
- 16.5.7. Application
- 16.5.8. End User
- 16.6. Japan AI in Epidemiology Market
- 16.6.1. Country Segmental Analysis
- 16.6.2. Component
- 16.6.3. Technology
- 16.6.4. Deployment Mode
- 16.6.5. Disease Type
- 16.6.6. Data Source
- 16.6.7. Application
- 16.6.8. End User
- 16.7. South Korea AI in Epidemiology Market
- 16.7.1. Country Segmental Analysis
- 16.7.2. Component
- 16.7.3. Technology
- 16.7.4. Deployment Mode
- 16.7.5. Disease Type
- 16.7.6. Data Source
- 16.7.7. Application
- 16.7.8. End User
- 16.8. Australia and New Zealand AI in Epidemiology Market
- 16.8.1. Country Segmental Analysis
- 16.8.2. Component
- 16.8.3. Technology
- 16.8.4. Deployment Mode
- 16.8.5. Disease Type
- 16.8.6. Data Source
- 16.8.7. Application
- 16.8.8. End User
- 16.9. Indonesia AI in Epidemiology Market
- 16.9.1. Country Segmental Analysis
- 16.9.2. Component
- 16.9.3. Technology
- 16.9.4. Deployment Mode
- 16.9.5. Disease Type
- 16.9.6. Data Source
- 16.9.7. Application
- 16.9.8. End User
- 16.10. Malaysia AI in Epidemiology Market
- 16.10.1. Country Segmental Analysis
- 16.10.2. Component
- 16.10.3. Technology
- 16.10.4. Deployment Mode
- 16.10.5. Disease Type
- 16.10.6. Data Source
- 16.10.7. Application
- 16.10.8. End User
- 16.11. Thailand AI in Epidemiology Market
- 16.11.1. Country Segmental Analysis
- 16.11.2. Component
- 16.11.3. Technology
- 16.11.4. Deployment Mode
- 16.11.5. Disease Type
- 16.11.6. Data Source
- 16.11.7. Application
- 16.11.8. End User
- 16.12. Vietnam AI in Epidemiology Market
- 16.12.1. Country Segmental Analysis
- 16.12.2. Component
- 16.12.3. Technology
- 16.12.4. Deployment Mode
- 16.12.5. Disease Type
- 16.12.6. Data Source
- 16.12.7. Application
- 16.12.8. End User
- 16.13. Rest of Asia Pacific AI in Epidemiology Market
- 16.13.1. Country Segmental Analysis
- 16.13.2. Component
- 16.13.3. Technology
- 16.13.4. Deployment Mode
- 16.13.5. Disease Type
- 16.13.6. Data Source
- 16.13.7. Application
- 16.13.8. End User
- 17. Middle East AI in Epidemiology Market Analysis
- 17.1. Key Segment Analysis
- 17.2. Regional Snapshot
- 17.3. Middle East AI in Epidemiology Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 17.3.1. Component
- 17.3.2. Technology
- 17.3.3. Deployment Mode
- 17.3.4. Disease Type
- 17.3.5. Data Source
- 17.3.6. Application
- 17.3.7. End User
- 17.3.8. Country
- 17.3.8.1. Turkey
- 17.3.8.2. UAE
- 17.3.8.3. Saudi Arabia
- 17.3.8.4. Israel
- 17.3.8.5. Rest of Middle East
- 17.4. Turkey AI in Epidemiology Market
- 17.4.1. Country Segmental Analysis
- 17.4.2. Component
- 17.4.3. Technology
- 17.4.4. Deployment Mode
- 17.4.5. Disease Type
- 17.4.6. Data Source
- 17.4.7. Application
- 17.4.8. End User
- 17.5. UAE AI in Epidemiology Market
- 17.5.1. Country Segmental Analysis
- 17.5.2. Component
- 17.5.3. Technology
- 17.5.4. Deployment Mode
- 17.5.5. Disease Type
- 17.5.6. Data Source
- 17.5.7. Application
- 17.5.8. End User
- 17.6. Saudi Arabia AI in Epidemiology Market
- 17.6.1. Country Segmental Analysis
- 17.6.2. Component
- 17.6.3. Technology
- 17.6.4. Deployment Mode
- 17.6.5. Disease Type
- 17.6.6. Data Source
- 17.6.7. Application
- 17.6.8. End User
- 17.7. Israel AI in Epidemiology Market
- 17.7.1. Country Segmental Analysis
- 17.7.2. Component
- 17.7.3. Technology
- 17.7.4. Deployment Mode
- 17.7.5. Disease Type
- 17.7.6. Data Source
- 17.7.7. Application
- 17.7.8. End User
- 17.8. Rest of Middle East AI in Epidemiology Market
- 17.8.1. Country Segmental Analysis
- 17.8.2. Component
- 17.8.3. Technology
- 17.8.4. Deployment Mode
- 17.8.5. Disease Type
- 17.8.6. Data Source
- 17.8.7. Application
- 17.8.8. End User
- 18. Africa AI in Epidemiology Market Analysis
- 18.1. Key Segment Analysis
- 18.2. Regional Snapshot
- 18.3. Africa AI in Epidemiology Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 18.3.1. Component
- 18.3.2. Technology
- 18.3.3. Deployment Mode
- 18.3.4. Disease Type
- 18.3.5. Data Source
- 18.3.6. Application
- 18.3.7. End User
- 18.3.8. Country
- 18.3.8.1. South Africa
- 18.3.8.2. Egypt
- 18.3.8.3. Nigeria
- 18.3.8.4. Algeria
- 18.3.8.5. Rest of Africa
- 18.4. South Africa AI in Epidemiology Market
- 18.4.1. Country Segmental Analysis
- 18.4.2. Component
- 18.4.3. Technology
- 18.4.4. Deployment Mode
- 18.4.5. Disease Type
- 18.4.6. Data Source
- 18.4.7. Application
- 18.4.8. End User
- 18.5. Egypt AI in Epidemiology Market
- 18.5.1. Country Segmental Analysis
- 18.5.2. Component
- 18.5.3. Technology
- 18.5.4. Deployment Mode
- 18.5.5. Disease Type
- 18.5.6. Data Source
- 18.5.7. Application
- 18.5.8. End User
- 18.6. Nigeria AI in Epidemiology Market
- 18.6.1. Country Segmental Analysis
- 18.6.2. Component
- 18.6.3. Technology
- 18.6.4. Deployment Mode
- 18.6.5. Disease Type
- 18.6.6. Data Source
- 18.6.7. Application
- 18.6.8. End User
- 18.7. Algeria AI in Epidemiology Market
- 18.7.1. Country Segmental Analysis
- 18.7.2. Component
- 18.7.3. Technology
- 18.7.4. Deployment Mode
- 18.7.5. Disease Type
- 18.7.6. Data Source
- 18.7.7. Application
- 18.7.8. End User
- 18.8. Rest of Africa AI in Epidemiology Market
- 18.8.1. Country Segmental Analysis
- 18.8.2. Component
- 18.8.3. Technology
- 18.8.4. Deployment Mode
- 18.8.5. Disease Type
- 18.8.6. Data Source
- 18.8.7. Application
- 18.8.8. End User
- 19. South America AI in Epidemiology Market Analysis
- 19.1. Key Segment Analysis
- 19.2. Regional Snapshot
- 19.3. South America AI in Epidemiology Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 19.3.1. Component
- 19.3.2. Technology
- 19.3.3. Deployment Mode
- 19.3.4. Disease Type
- 19.3.5. Data Source
- 19.3.6. Application
- 19.3.7. End User
- 19.3.8. Country
- 19.3.8.1. Brazil
- 19.3.8.2. Argentina
- 19.3.8.3. Rest of South America
- 19.4. Brazil AI in Epidemiology Market
- 19.4.1. Country Segmental Analysis
- 19.4.2. Component
- 19.4.3. Technology
- 19.4.4. Deployment Mode
- 19.4.5. Disease Type
- 19.4.6. Data Source
- 19.4.7. Application
- 19.4.8. End User
- 19.5. Argentina AI in Epidemiology Market
- 19.5.1. Country Segmental Analysis
- 19.5.2. Component
- 19.5.3. Technology
- 19.5.4. Deployment Mode
- 19.5.5. Disease Type
- 19.5.6. Data Source
- 19.5.7. Application
- 19.5.8. End User
- 19.6. Rest of South America AI in Epidemiology Market
- 19.6.1. Country Segmental Analysis
- 19.6.2. Component
- 19.6.3. Technology
- 19.6.4. Deployment Mode
- 19.6.5. Disease Type
- 19.6.6. Data Source
- 19.6.7. Application
- 19.6.8. End User
- 20. Key Players/ Company Profile
- 20.1. Clarivate.
- 20.1.1. Company Details/ Overview
- 20.1.2. Company Financials
- 20.1.3. Key Customers and Competitors
- 20.1.4. Business/ Industry Portfolio
- 20.1.5. Product Portfolio/ Specification Details
- 20.1.6. Pricing Data
- 20.1.7. Strategic Overview
- 20.1.8. Recent Developments
- 20.2. Databricks, Inc.
- 20.3. International Business Machines Corporation (IBM)
- 20.4. IQVIA Inc.
- 20.5. SAS Institute Inc.
- 20.6. theBlue.ai GmbH
- 20.7. Veradigm LLC
- 20.8. Other Key Players
- 20.1. Clarivate.
Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography
Research Design
Our research design integrates both demand-side and supply-side analysis through a balanced combination of primary and secondary research methodologies. By utilizing both bottom-up and top-down approaches alongside rigorous data triangulation methods, we deliver robust market intelligence that supports strategic decision-making.
MarketGenics' comprehensive research design framework ensures the delivery of accurate, reliable, and actionable market intelligence. Through the integration of multiple research approaches, rigorous validation processes, and expert analysis, we provide our clients with the insights needed to make informed strategic decisions and capitalize on market opportunities.
MarketGenics leverages a dedicated industry panel of experts and a comprehensive suite of paid databases to effectively collect, consolidate, and analyze market intelligence.
Our approach has consistently proven to be reliable and effective in generating accurate market insights, identifying key industry trends, and uncovering emerging business opportunities.
Through both primary and secondary research, we capture and analyze critical company-level data such as manufacturing footprints, including technical centers, R&D facilities, sales offices, and headquarters.
Our expert panel further enhances our ability to estimate market size for specific brands based on validated field-level intelligence.
Our data mining techniques incorporate both parametric and non-parametric methods, allowing for structured data collection, sorting, processing, and cleaning.
Demand projections are derived from large-scale data sets analyzed through proprietary algorithms, culminating in robust and reliable market sizing.
Research Approach
The bottom-up approach builds market estimates by starting with the smallest addressable market units and systematically aggregating them to create comprehensive market size projections.
This method begins with specific, granular data points and builds upward to create the complete market landscape.
Customer Analysis → Segmental Analysis → Geographical Analysis
The top-down approach starts with the broadest possible market data and systematically narrows it down through a series of filters and assumptions to arrive at specific market segments or opportunities.
This method begins with the big picture and works downward to increasingly specific market slices.
TAM → SAM → SOM
Research Methods
Desk / Secondary Research
While analysing the market, we extensively study secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and commercial report. Secondary sources that we utilize are not only the public sources, but it is a combination of Open Source, Associations, Paid Databases, MG Repository & Knowledgebase, and others.
- Company websites, annual reports, financial reports, broker reports, and investor presentations
- National government documents, statistical databases and reports
- News articles, press releases and web-casts specific to the companies operating in the market, Magazines, reports, and others
- We gather information from commercial data sources for deriving company specific data such as segmental revenue, share for geography, product revenue, and others
- Internal and external proprietary databases (industry-specific), relevant patent, and regulatory databases
- Governing Bodies, Government Organizations
- Relevant Authorities, Country-specific Associations for Industries
We also employ the model mapping approach to estimate the product level market data through the players' product portfolio
Primary Research
Primary research/ interviews is vital in analyzing the market. Most of the cases involves paid primary interviews. Primary sources include primary interviews through e-mail interactions, telephonic interviews, surveys as well as face-to-face interviews with the different stakeholders across the value chain including several industry experts.
| Type of Respondents | Number of Primaries |
|---|---|
| Tier 2/3 Suppliers | ~20 |
| Tier 1 Suppliers | ~25 |
| End-users | ~25 |
| Industry Expert/ Panel/ Consultant | ~30 |
| Total | ~100 |
MG Knowledgebase
• Repository of industry blog, newsletter and case studies
• Online platform covering detailed market reports, and company profiles
Forecasting Factors and Models
Forecasting Factors
- Historical Trends – Past market patterns, cycles, and major events that shaped how markets behave over time. Understanding past trends helps predict future behavior.
- Industry Factors – Specific characteristics of the industry like structure, regulations, and innovation cycles that affect market dynamics.
- Macroeconomic Factors – Economic conditions like GDP growth, inflation, and employment rates that affect how much money people have to spend.
- Demographic Factors – Population characteristics like age, income, and location that determine who can buy your product.
- Technology Factors – How quickly people adopt new technology and how much technology infrastructure exists.
- Regulatory Factors – Government rules, laws, and policies that can help or restrict market growth.
- Competitive Factors – Analyzing competition structure such as degree of competition and bargaining power of buyers and suppliers.
Forecasting Models / Techniques
Multiple Regression Analysis
- Identify and quantify factors that drive market changes
- Statistical modeling to establish relationships between market drivers and outcomes
Time Series Analysis – Seasonal Patterns
- Understand regular cyclical patterns in market demand
- Advanced statistical techniques to separate trend, seasonal, and irregular components
Time Series Analysis – Trend Analysis
- Identify underlying market growth patterns and momentum
- Statistical analysis of historical data to project future trends
Expert Opinion – Expert Interviews
- Gather deep industry insights and contextual understanding
- In-depth interviews with key industry stakeholders
Multi-Scenario Development
- Prepare for uncertainty by modeling different possible futures
- Creating optimistic, pessimistic, and most likely scenarios
Time Series Analysis – Moving Averages
- Sophisticated forecasting for complex time series data
- Auto-regressive integrated moving average models with seasonal components
Econometric Models
- Apply economic theory to market forecasting
- Sophisticated economic models that account for market interactions
Expert Opinion – Delphi Method
- Harness collective wisdom of industry experts
- Structured, multi-round expert consultation process
Monte Carlo Simulation
- Quantify uncertainty and probability distributions
- Thousands of simulations with varying input parameters
Research Analysis
Our research framework is built upon the fundamental principle of validating market intelligence from both demand and supply perspectives. This dual-sided approach ensures comprehensive market understanding and reduces the risk of single-source bias.
Demand-Side Analysis: We understand end-user/application behavior, preferences, and market needs along with the penetration of the product for specific application.
Supply-Side Analysis: We estimate overall market revenue, analyze the segmental share along with industry capacity, competitive landscape, and market structure.
Validation & Evaluation
Data triangulation is a validation technique that uses multiple methods, sources, or perspectives to examine the same research question, thereby increasing the credibility and reliability of research findings. In market research, triangulation serves as a quality assurance mechanism that helps identify and minimize bias, validate assumptions, and ensure accuracy in market estimates.
- Data Source Triangulation – Using multiple data sources to examine the same phenomenon
- Methodological Triangulation – Using multiple research methods to study the same research question
- Investigator Triangulation – Using multiple researchers or analysts to examine the same data
- Theoretical Triangulation – Using multiple theoretical perspectives to interpret the same data
Custom Market Research Services
We will customise the research for you, in case the report listed above does not meet your requirements.
Get 10% Free Customisation